Article
Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients.
Neuroscience letters - 22 Sept 2009
Begni Barbara, Tremolizzo Lucio, Andreoni Simona, Contri Margherita, Uccellini Orlando, Neri Francesca, Ferrarese Carlo
Abstract excerpt
Neurotransmitter ligand binding in blood cells was assessed in borderline personality disorder (BDP) patients, testing the possibility that different biochemical endophenotypes might lie beneath a specific clinical presentation. The density of peripheral benzodiazepine receptors (PBR) and serotonin transporters were assessed in peripheral blood mononuclear cells (PBMC) and platelets, respectively, showing a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
